Study of Viral Transduction of Human Auditory Sensory Cells for the Development of Gene Therapy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Pasteur

About this trial

Gene therapy is a promising strategy to treat hearing loss and vestibular disorders, and Associated adenovirus (AAV) is shown as a good viral vector for inner ear therapy in animal models.

This study aims to study in vitro viral transduction of AAV in human inner ear cells, collected during non-conservative surgeries for vestibular schwannoma.

Eligibility criteria

Qualifiers

Patient ≥ 18 years old

Operative indication for a non-conservative resection of vestibular schwannoma, decided by the surgeon in accordance with the patient

Informed consent obtained

Patients with a french social protection (AME excluded)

Disqualifiers

Intravestibular or intra-cochlear extension of the tumor

Pregnant woman

Patient with administrative control

Medical contra-indication

Trial design

Treatments tested in this trial

  • Peroperative collect of inner ear cells

Treatment groups

100 Participants
are divided into 1 treatment group

Sponsors and collaborators

Institut Pasteur

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Collaborator